Matches in Wikidata for { <http://www.wikidata.org/entity/Q98603874> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q98603874 description "clinical trial" @default.
- Q98603874 description "ensayo clínico" @default.
- Q98603874 description "ensayu clínicu" @default.
- Q98603874 description "klinisch onderzoek" @default.
- Q98603874 description "клінічне випробування" @default.
- Q98603874 description "临床试验" @default.
- Q98603874 name "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 name "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 type Item @default.
- Q98603874 label "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 label "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 prefLabel "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 prefLabel "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 P1050 Q98603874-8D6BA41C-0B83-4A71-A03E-935180B8DD91 @default.
- Q98603874 P1132 Q98603874-3D6DE14D-5417-489F-9EBB-6A9FEE8FC009 @default.
- Q98603874 P1476 Q98603874-60237103-98BB-423B-A855-4FEA3BBA65EB @default.
- Q98603874 P17 Q98603874-BD9B9DBD-A591-4687-8F7A-39EDFFC53274 @default.
- Q98603874 P2899 Q98603874-2146DD5F-4C7B-4EC9-8F6B-02840A541E47 @default.
- Q98603874 P3098 Q98603874-B2B0A951-4F63-41EA-8892-E8BF5D70AB8A @default.
- Q98603874 P31 Q98603874-B8933D29-4E1B-4BD4-A86D-1F0C5C607EF4 @default.
- Q98603874 P4135 Q98603874-AB8D30DB-F430-45DC-9218-D4EAB1333035 @default.
- Q98603874 P580 Q98603874-479FA3D7-8A8A-41B5-A5D0-14897C97D10B @default.
- Q98603874 P582 Q98603874-942F8860-81A7-465C-8AAC-0FE717DBD1FC @default.
- Q98603874 P6099 Q98603874-891696C2-4512-44C9-ADAA-67AF5B85F30D @default.
- Q98603874 P8005 Q98603874-8EA1160F-1938-4E4C-AAF5-F7A598BBA27B @default.
- Q98603874 P8363 Q98603874-9C4451F7-3177-43AF-A2C1-911583F9E801 @default.
- Q98603874 P1050 Q101991 @default.
- Q98603874 P1132 "+100" @default.
- Q98603874 P1476 "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients" @default.
- Q98603874 P17 Q843 @default.
- Q98603874 P2899 "+18" @default.
- Q98603874 P3098 "NCT04468646" @default.
- Q98603874 P31 Q30612 @default.
- Q98603874 P4135 "+90" @default.
- Q98603874 P580 "2020-06-15T00:00:00Z" @default.
- Q98603874 P582 "2020-07-15T00:00:00Z" @default.
- Q98603874 P6099 Q42824827 @default.
- Q98603874 P8005 Q76649708 @default.
- Q98603874 P8363 Q78089383 @default.